Xi'an High-tech Hospital 204 Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jia, Yi
CRAD-001-03, NCT05295173: A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）

Completed
3
1412
RoW
Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA
Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital
Acute Ischemic Stroke
06/23
06/23
NCT05998902: Optimizing Early Nutrition Support in Severe Stroke-2

Recruiting
3
546
RoW
Trophic enteral feeding combined with supplemental parenteral nutrition, Full enteral feeding
Wen Jiang-3, Tang-Du Hospital, Xi'an Central Hospital, Xi'an Gaoxin Hospital, First Affiliated Hospital of Xi'an Medical University, Xi'an No.3 Hospital, First People's Hospital of Xianyang, Nanfang Hospital, Southern Medical University, Tongji Hospital, Qilu Hospital of Shandong University, The Second Hospital of Shandong University, PLA 960 Hospital, Daping Hospital, The Third Military Medical University (Army Medical University), The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, First Hospital Affiliated to Zhengzhou University, Gansu Provincial Central Hospital, The First Hospital of Changsha City, Shaanxi Provincial People's Hospital, Yulin No.2 Hospital, Yulin No.1 Hospital, Xijing Hospital
Severe Stroke, Acute Stroke, Dysphagia
07/26
10/26
NCT05686642: Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

Recruiting
2
300
RoW
LT3001 Drug:high dose, Placebo, LT3001 Drug:low dose
Shanghai Pharmaceuticals Holding Co., Ltd
Acute Ischemic Stroke
04/25
07/25
AIM, NCT05032053: Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds

Recruiting
N/A
3000
RoW
Antithrombotic drugs
Xijing Hospital, Ankang Central Hospital, Yan'an University Affiliated Hospital
Ischemic Stroke
12/25
10/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jia, Yi
CRAD-001-03, NCT05295173: A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）

Completed
3
1412
RoW
Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA
Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital
Acute Ischemic Stroke
06/23
06/23
NCT05998902: Optimizing Early Nutrition Support in Severe Stroke-2

Recruiting
3
546
RoW
Trophic enteral feeding combined with supplemental parenteral nutrition, Full enteral feeding
Wen Jiang-3, Tang-Du Hospital, Xi'an Central Hospital, Xi'an Gaoxin Hospital, First Affiliated Hospital of Xi'an Medical University, Xi'an No.3 Hospital, First People's Hospital of Xianyang, Nanfang Hospital, Southern Medical University, Tongji Hospital, Qilu Hospital of Shandong University, The Second Hospital of Shandong University, PLA 960 Hospital, Daping Hospital, The Third Military Medical University (Army Medical University), The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, First Hospital Affiliated to Zhengzhou University, Gansu Provincial Central Hospital, The First Hospital of Changsha City, Shaanxi Provincial People's Hospital, Yulin No.2 Hospital, Yulin No.1 Hospital, Xijing Hospital
Severe Stroke, Acute Stroke, Dysphagia
07/26
10/26
NCT05686642: Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

Recruiting
2
300
RoW
LT3001 Drug:high dose, Placebo, LT3001 Drug:low dose
Shanghai Pharmaceuticals Holding Co., Ltd
Acute Ischemic Stroke
04/25
07/25
AIM, NCT05032053: Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds

Recruiting
N/A
3000
RoW
Antithrombotic drugs
Xijing Hospital, Ankang Central Hospital, Yan'an University Affiliated Hospital
Ischemic Stroke
12/25
10/26

Download Options